We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

184 hedge funds and large institutions have $761M invested in Acorda Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 41

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

3% more funds holding

Funds holding: 179 → 184 (+5)

8% less capital invested

Capital invested by funds: $826M → $761M (-$65M)

52% less call options, than puts

Call options by funds: $2.4M | Put options by funds: $5.05M

Holders
184
Holders Change
+5
Holders Change %
+2.79%
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
79
Reduced
41
Closed
21
Calls
$2.4M
Puts
$5.05M
Net Calls
-$2.65M
Net Calls Change
-$26M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$27.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11.5M
3
State Street
State Street
Massachusetts
+$9.6M
4
Prudential Financial
Prudential Financial
New Jersey
+$6.06M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$17.3M
2
Invesco
Invesco
Georgia
-$17.1M
3
SCM
Scopia Capital Management
New York
-$15.5M
4
Millennium Management
Millennium Management
New York
-$11M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
76
GSA Capital Partners
United Kingdom
$869K +$66.7K +37 +7%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$819K +$249K +138 +37%
ASRS
78
Arizona State Retirement System
Arizona
$811K +$1.8K +1 +0.2%
New York State Teachers Retirement System (NYSTRS)
79
New York State Teachers Retirement System (NYSTRS)
New York
$788K – – –
CS
80
Credit Suisse
Switzerland
$774K -$313K -174 -26%
AIM
81
Assured Investment Management
New York
$767K +$39.6K +22 +5%
California Public Employees Retirement System
82
California Public Employees Retirement System
California
$758K -$393K -218 -31%
DekaBank Deutsche Girozentrale
83
DekaBank Deutsche Girozentrale
Germany
$735K +$48.6K +27 +14%
SO
84
STRS Ohio
Ohio
$676K +$132K +73 +21%
Canada Life
85
Canada Life
Manitoba, Canada
$667K – – –
QIM
86
Quantitative Investment Management
Virginia
$648K +$548K +304 +295%
VEA
87
Virtus ETF Advisers
New York
$644K +$171K +95 +31%
VOYA Investment Management
88
VOYA Investment Management
Georgia
$603K +$115K +64 +20%
Balyasny Asset Management
89
Balyasny Asset Management
Illinois
$590K -$4.28M -2,376 -87%
JIR
90
James Investment Research
Ohio
$535K +$180K +100 +42%
Comerica Bank
91
Comerica Bank
Texas
$502K +$14.4K +8 +3%
JG
92
Jefferies Group
New York
$491K -$796K -442 -59%
Barclays
93
Barclays
United Kingdom
$491K -$202K -112 -27%
ASN
94
Advisory Services Network
Georgia
$485K +$362K +201 +195%
WCM
95
Wedge Capital Management
North Carolina
$485K +$548K +304 New
Public Sector Pension Investment Board (PSP Investments)
96
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$460K – – –
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$449K -$1.8K -1 -0.4%
AIG
98
American International Group
New York
$435K -$9.01K -5 -2%
Millennium Management
99
Millennium Management
New York
$420K -$11M -6,097 -96%
MAM
100
Martingale Asset Management
Massachusetts
$402K – – –
2 3
4
5 6

ACOR Hedge Fund Activity: Q1 2019 in Review

184 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q1 2019, worth a combined $761M — down 7.9% from $826M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 21 closed out — a net gain of 5 holders — while 79 added to existing stakes and 41 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $27.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $17.3M sold.

  • 184 institutional investors held Acorda Therapeutics (ACOR) as of Q1 2019, up from 179 in Q4 2018.
  • Funds reported $761M of Acorda Therapeutics stock for Q1 2019, down 7.9% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q1 2019 and 21 closed out, a net change of +5 holders.
  • The largest Acorda Therapeutics buyer in Q1 2019 was Renaissance Technologies, an estimated $27.4M added.
  • The largest Acorda Therapeutics seller in Q1 2019 was PFM Health Sciences, an estimated $17.3M sold.

Based on aggregated 13F filings for Q1 2019.